Epidermal growth factor receptor inhibitors for treatment of orbital squamous cell carcinoma

Arch Ophthalmol. 2012 Dec;130(12):1608-11. doi: 10.1001/archophthalmol.2012.2515.
No abstract available

Publication types

  • Case Reports
  • Research Support, N.I.H., Extramural

MeSH terms

  • Aged, 80 and over
  • Antibodies, Monoclonal, Humanized / pharmacology
  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Antineoplastic Agents / pharmacology
  • Antineoplastic Agents / therapeutic use
  • Carcinoma, Squamous Cell / drug therapy*
  • Cetuximab
  • Epidermal Growth Factor / antagonists & inhibitors*
  • Erlotinib Hydrochloride
  • Female
  • Humans
  • Male
  • Orbital Neoplasms / drug therapy*
  • Protein Kinase Inhibitors / antagonists & inhibitors
  • Quinazolines / pharmacology
  • Quinazolines / therapeutic use*

Substances

  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • Protein Kinase Inhibitors
  • Quinazolines
  • Epidermal Growth Factor
  • Erlotinib Hydrochloride
  • Cetuximab